These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33951974)

  • 21. Hazardous Drug Residues in the Home Setting: Worker Safety Concerns.
    Huff C
    J Infus Nurs; 2020; 43(1):15-18. PubMed ID: 31876769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy Safe Handling: Limiting Nursing Exposure With a Hazardous Drug Control Program.
    Crickman R
    Clin J Oncol Nurs; 2017 Feb; 21(1):73-78. PubMed ID: 28107320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antineoplastic agents and biologic response modifiers in oncologic hematology].
    Cabrera Marín JR; Briz del Blanco M
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():3-13. PubMed ID: 10422445
    [No Abstract]   [Full Text] [Related]  

  • 24. Safe Handling of Hazardous Drugs: ASCO Standards.
    Celano P; Fausel CA; Kennedy EB; Miller TM; Oliver TK; Page R; Ward JC; Zon RT
    J Clin Oncol; 2019 Mar; 37(7):598-609. PubMed ID: 30620670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncology Conference Highlights, Q4.
    Leavitt J; DeVito T; Saleh N
    Oncology (Williston Park); 2019 Jan; 33(1):8-10. PubMed ID: 30731012
    [No Abstract]   [Full Text] [Related]  

  • 26. American Society of Clinical Oncology Annual Meeting 2019.
    Del Pozo Martín Y
    Lancet Haematol; 2019 Jul; 6(7):e349. PubMed ID: 31182415
    [No Abstract]   [Full Text] [Related]  

  • 27. Abstracts of the American Society of Pediatric Hematology/Oncology (ASPHO) 26th Annual Meeting. Miami, Florida, USA. April 24-27, 2013.
    Pediatr Blood Cancer; 2013 Jun; 60 Suppl 2():S1-105. PubMed ID: 23596123
    [No Abstract]   [Full Text] [Related]  

  • 28. American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA.
    Walker K
    IDrugs; 2007 Feb; 10(2):78-80. PubMed ID: 17285452
    [No Abstract]   [Full Text] [Related]  

  • 29. Personal Protective Equipment: Evaluating Usage Among Inpatient and Outpatient Oncology Nurses.
    Menonna-Quinn D; Polovich M; Marshall B
    Clin J Oncol Nurs; 2019 Jun; 23(3):260-265. PubMed ID: 31099797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016.
    Zhou J; Vallejo J; Kluetz P; Pazdur R; Kim T; Keegan P; Farrell A; Beaver JA; Sridhara R
    J Natl Cancer Inst; 2019 May; 111(5):449-458. PubMed ID: 30085269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Care: Safe Drug Handling of Oral Chemotherapy.
    Johnson TM
    Consult Pharm; 2017 Feb; 32(2):74-83. PubMed ID: 28569658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ambulatory chemotherapy in hematology. A challenge ...].
    Montagne C; Duran B
    Soins; 1996 Sep; (608):62-8. PubMed ID: 8954491
    [No Abstract]   [Full Text] [Related]  

  • 34. American Society of Hematology--50th Annual Meeting and Exposition--Part 1.
    Scattereggia J; Millar E
    IDrugs; 2009 Feb; 12(2):63-5. PubMed ID: 19216123
    [No Abstract]   [Full Text] [Related]  

  • 35. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology.
    Neuss MN; Gilmore TR; Belderson KM; Billett AL; Conti-Kalchik T; Harvey BE; Hendricks C; LeFebvre KB; Mangu PB; McNiff K; Olsen M; Schulmeister L; Von Gehr A; Polovich M
    J Oncol Pract; 2016 Dec; 12(12):1262-1271. PubMed ID: 27868581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely?
    Ravindran A; Gonsalves WI; Hashmi SK; Kapoor P; Marshall AL; Siddiqui MA; Go RS
    Leuk Lymphoma; 2017 Jan; 58(1):251-252. PubMed ID: 27282880
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings of the Initial Meeting of the Society of Hematologic Oncology 2013, September 18-21, 2013, Houston, Texas.
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S1-113. PubMed ID: 26280054
    [No Abstract]   [Full Text] [Related]  

  • 39. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality and safety in pediatric hematology/oncology.
    Mueller BU
    Pediatr Blood Cancer; 2014 Jun; 61(6):966-9. PubMed ID: 24481936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.